Moreover, NA49 also showed sensitization in Gef-resistant NSCLC cells with secondary mutation of EGFR such as T790M, suggesting that HSP27 inhibition can overcome Gef resistance, which is mediated by diverse pathways. Here, EGFR is linked to non-small cell lung carcinoma.